Non Animal Testing Database
EnglischDeutsch
Download XML for Micrsoft Excel
Download CSV for Microsoft Excel
Copy search query
Print / PDF

BioNTech use artificial intelligence to develop COVID-19 therapeutics and vaccines

Company
December 2020
InstaDeep, London, United Kingdom
#artificial intelligence, #COVID-19, #machine learning, #vaccines
The biopharmaceutical company BioNTech and the Artificial Intelligence (AI) product developer InstaDeep collaborate by using AI and machine learning to discover decoy proteins with a potentially higher binding affinity than that of the human receptor, which the coronavirus uses to attack cells. Such proteins would prevent the sequence of events leading to the release of the viral genome and viral replication. In the future, the two companies will work together to discover and develop novel immunotherapies like mRNA-based vaccines.
Designing a prospective COVID-19 therapeutic with reinforcement learning
Marcin J. Skwark

Marcin J. Skwark et al. arXiv 2020 [1]   URL
InstaDeep [2]   URL
#476
Added on: 02-05-2021
[1] https://arxiv.org/abs/2012.01736[2] https://www.instadeep.com/2020/12/first-joint-instadeep-biontech-research-paper-accepted-at-the-neurips-ai-conference/
Back to Top
English German
Project of


Supported by


Logo
Lush Prize Winner 2022


Lush Prize Winner 2022
Winner of the Animal Protection Prize of Lower Saxony 2022

Winner of the Animal Protection Prize of Lower Saxony 2022

Suscribe to RSS Feed Legal Notice Privacy Policy

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!